Plasmacytoid dendritic cells are dispensable or detrimental in murine systemic or respiratory viral infections
Clemence Ngo, Camille Pierini-Malosse, Khalissa Rahmani, Michael ValenteiD, Nils Collinet, Gilles Bessou, Capucine Guerry, Manon Fabregue, Solene Mathieu, Sarah Sharkaoui, Sophie MazzoliiD, Amandine Sansoni, Frédéric FIOREiD, Caroline LaprieiD, Lena AlexopoulouiD, Mauro GayaiD, Claude GrégoireiD, Achille BroggiiD, Sarah Wurbel, Réjane RuaiD, Narjess Haidar, Pierre MilpiediD, Bertrand Escalière, Thien‐Phong Vu ManhiD, Mathieu FalletiD, , Elena TomaselloiD
Abstract
Plasmacytoid dendritic cells (pDCs) are major producers of type I/III interferons. As interferons are crucial for antiviral defense, pDCs are assumed to play an essential role in this process. However, robust evidence supporting this dogma is scarce. Genetic or pharmacological manipulations that eliminate pDC or disrupt their interferon production often affect other cells, confounding interpretation. To overcome this issue, we engineered pDC-less mice that are specifically and constitutively devoid of pDCs by expressing diphtheria toxin under coordinated control of the Siglech and Pacsin1 genes, uniquely co-expressed in pDCs. pDC-less mice mounted protective immunity against systemic infection with mouse Cytomegalovirus and showed higher survival and less lung immunopathology to intranasal infection with influenza virus and SARS-CoV2. Thus, contrary to the prevailing dogma, we revealed that pDCs and their interferons are dispensable or deleterious during several viral infections. pDC-less mice will enable rigorously reassessing the roles of pDCs in health and disease.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 13
- FWCI
- 3.91
- Field percentile
- top 5%
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Plasmacytoid dendritic cells produce type I interferon and reduce viral replication in airway epithelial cells after SARS-CoV-2 infection
L. Cervantes-Barragan, A. Vanderheiden, … M. S. Suthar·bioRxiv·May 12, 2021
- Genomic Analysis of Progenitors in Viral Infection Implicates Glucocorticoids as Suppressors of Plasmacytoid Dendritic Cell Generation
Yeara Jo, Trever T. Greene, … Elina I. Zúñiga·Proceedings of the National Academy of SciencesPeer-reviewed·Apr 28, 2025
- Antiviral Response by Plasmacytoid Dendritic Cells via Interferogenic Synapse with Infected Cells
- Metabolic Deficiencies Underlie Plasmacytoid Dendritic Cell Exhaustion After Viral Infection
Trever T. Greene, Yeara Jo, … Elina I. Zúñiga·Nature CommunicationsPeer-reviewed·Feb 7, 2025
- Differential plasmacytoid dendritic cell phenotype and type I Interferon response in asymptomatic and severe COVID-19 infection
M. Severa, R. A. Diotti, … E. Coccia·bioRxiv·Apr 17, 2021
- A novel mouse model based on intersectional genetics enables unambiguous in vivo discrimination between plasmacytoid and other dendritic cells and their comparative characterization
M. Valente, N. Collinet, … M. Dalod·bioRxiv·Jan 7, 2022